Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 499

1.
2.
3.

Impact of cost sharing on prescription drugs used by Medicare beneficiaries.

Goedken AM, Urmie JM, Farris KB, Doucette WR.

Res Social Adm Pharm. 2010 Jun;6(2):100-9. doi: 10.1016/j.sapharm.2010.03.003. Epub 2010 May 7.

PMID:
20511109
4.

A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.

Clark BE, Siracuse MV, Garis RI.

Res Social Adm Pharm. 2009 Jun;5(2):133-42. doi: 10.1016/j.sapharm.2008.06.002. Epub 2009 Jan 31.

PMID:
19524861
5.

Impact of health plan design and management on retirees' prescription drug use and spending, 2001.

Thomas CP, Wallack SS, Lee S, Ritter GA.

Health Aff (Millwood). 2002 Jul-Dec;Suppl Web Exclusives:W408-19.

6.

The association of insurance type with costs of dispensed drugs.

Mott DA, Kreling DH.

Inquiry. 1998 Spring;35(1):23-35.

PMID:
9597015
7.

Employers push to manage prescription drug costs.

Frieden J.

Bus Health. 1992 May;10(6):43-6, 48, 50. No abstract available.

PMID:
10119119
8.

Who bears the burden of Medicaid drug copayment policies?

Stuart B, Zacker C.

Health Aff (Millwood). 1999 Mar-Apr;18(2):201-12.

9.

Managing prescription drug costs.

Sica JM.

Empl Benefits J. 2001 Mar;26(1):35-40.

PMID:
11272515
10.

The effect of incentive-based formularies on prescription-drug utilization and spending.

Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Frank RG.

N Engl J Med. 2003 Dec 4;349(23):2224-32.

11.

Rising drug costs: the impact on dermatology.

Rico MJ.

Skin Therapy Lett. 2000;5(4):1-2,5.

PMID:
10785406
12.

Do drug copayments work?

David J.

CMAJ. 1994 May 1;150(9):1491-3. No abstract available.

13.

Out-of-pocket costs to users: medicine options for hypertension.

Arredondo A.

Am J Hypertens. 2008 May;21(5):492. doi: 10.1038/ajh.2008.150. No abstract available.

PMID:
18437138
14.

Managing the intricate Web of prescription drugs.

Eber BL.

Benefits Q. 2003;19(1):45-50.

PMID:
12608118
15.

Effects of changes in patient cost sharing and drug sample policies on prescription drug costs and utilization in a safety-net-provider setting.

Lurk JT, DeJong DJ, Woods TM, Knell ME, Carroll CA.

Am J Health Syst Pharm. 2004 Feb 1;61(3):267-72.

PMID:
14986557
16.

Employer drug benefit plans and spending on prescription drugs.

Joyce GF, Escarce JJ, Solomon MD, Goldman DP.

JAMA. 2002 Oct 9;288(14):1733-9. Erratum in: JAMA 2002 Nov 20;288(19):2409.

PMID:
12365957
17.
18.

Out-of-pocket and total costs of fixed-dose combination antihypertensives and their components.

Rabbani A, Alexander GC.

Am J Hypertens. 2008 May;21(5):509-13. doi: 10.1038/ajh.2008.31. Epub 2008 Mar 20.

PMID:
18437141
19.

Impact of pharmacy benefit design on prescription drug utilization: a fixed effects analysis of plan sponsor data.

Roebuck MC, Liberman JN.

Health Serv Res. 2009 Jun;44(3):988-1009. doi: 10.1111/j.1475-6773.2008.00943.x. Epub 2009 Jan 28.

20.

Effect of a three-tier prescription copay on pharmaceutical and other medical utilization.

Motheral B, Fairman KA.

Med Care. 2001 Dec;39(12):1293-304.

PMID:
11717571

Supplemental Content

Support Center